Intensive Versus Subcutaneous Insulin in Patients With Hyperacute Stroke | Zendy

Charlotte Rosso | Zendy; JeanChristophe Corvol | Zendy; Christine Pires | Zendy; Sophie Crozier | Zendy; Yohan Attal | Zendy; Sophie Jacqueminet | Zendy; S. Deltour | Zendy; Gurkan Multlu | Zendy; Anne Léger | Zendy; Isabelle Meresse | Zendy; Christine Payan | Zendy; Didier Dormont | Zendy; Yves Samson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intensive Versus Subcutaneous Insulin in Patients With Hyperacute Stroke

Author(s) -

Charlotte Rosso,

JeanChristophe Corvol,

Christine Pires,

Sophie Crozier,

Yohan Attal,

Sophie Jacqueminet,

S. Deltour,

Gurkan Multlu,

Anne Léger,

Isabelle Meresse,

Christine Payan,

Didier Dormont,

Yves Samson

Publication year - 2012

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.112.657122

Subject(s) - medicine , stroke (engine) , insulin , diabetes mellitus , adverse effect , randomized controlled trial , surgery , endocrinology , mechanical engineering , engineering

Intensive insulin therapy (IIT) has not yet proven its efficacy on stroke prognosis or in the reduction of MRI infarct growth. The INSULINFARCT study aims at determining in patients with hyperacute stroke whether IIT, with a better control of poststroke hyperglycemia, would reduce subsequent MRI infarct growth than usual care with subcutaneous insulin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research